These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30203400)

  • 1. RUNX2 Promotes Malignant Progression in Glioma.
    Yamada D; Fujikawa K; Kawabe K; Furuta T; Nakada M; Takarada T
    Neurochem Res; 2018 Nov; 43(11):2047-2054. PubMed ID: 30203400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation by Runt related factor-2 of matrix metalloproteinase-13 in astrocytes.
    Takarada T; Yoneda Y
    Neurosci Lett; 2009 Feb; 451(2):99-104. PubMed ID: 19121369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.
    Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B
    Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Runx2 is expressed in human glioma cells and mediates the expression of galectin-3.
    Vladimirova V; Waha A; Lückerath K; Pesheva P; Probstmeier R
    J Neurosci Res; 2008 Aug; 86(11):2450-61. PubMed ID: 18438928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
    Feng R; Dong L
    Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Hormone Receptor-β (TRβ) Mediates Runt-Related Transcription Factor 2 (Runx2) Expression in Thyroid Cancer Cells: A Novel Signaling Pathway in Thyroid Cancer.
    Carr FE; Tai PW; Barnum MS; Gillis NE; Evans KG; Taber TH; White JH; Tomczak JA; Jaworski DM; Zaidi SK; Lian JB; Stein JL; Stein GS
    Endocrinology; 2016 Aug; 157(8):3278-92. PubMed ID: 27253998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression.
    Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ
    Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-152 regulated glioma cell proliferation and apoptosis via Runx2 mediated by DNMT1.
    Zhang P; Sun H; Yang B; Luo W; Liu Z; Wang J; Zuo Y
    Biomed Pharmacother; 2017 Aug; 92():690-695. PubMed ID: 28595085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
    Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
    Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
    Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
    Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
    Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
    Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
    J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival.
    Kundu S; Xiong A; Spyrou A; Wicher G; Marinescu VD; Edqvist PD; Zhang L; Essand M; Dimberg A; Smits A; Ilan N; Vlodavsky I; Li JP; Forsberg-Nilsson K
    Mol Cancer Res; 2016 Dec; 14(12):1243-1253. PubMed ID: 27565180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
    Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
    Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.
    Choe M; Brusgard JL; Chumsri S; Bhandary L; Zhao XF; Lu S; Goloubeva OG; Polster BM; Fiskum GM; Girnun GD; Kim MS; Passaniti A
    J Cell Biochem; 2015 Oct; 116(10):2210-26. PubMed ID: 25808624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.